Malaria vaccine
US-2025230197-A1 · Jul 17, 2025 · US
Hepadnaviridae, e.g. hepatitis B virus
Hepadnaviridae, e.g. hepatitis B virus · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/02 |
| Official title | Hepadnaviridae, e.g. hepatitis B virus |
| Display label | Hepadnaviridae, e.g. hepatitis B virus |
| Total patents | 46 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Hepatitis B virus replication inhibitor and pharmaceutical composition for treating hepatitis B comprising the same
US-12275759-B2 · Apr 15, 2025 · US
Modified antimicrobial peptide derived from an arginine-rich domain
US-12084479-B2 · Sep 10, 2024 · US
Nucleic Acid Molecule Containing Incorporated Gene Encoding Fused Protein of Ligand and Protein Having Physiological Activity
US-2024066149-A1 · Feb 29, 2024 · US
Screening model and method for hbv cccdna-targeting drug
US-2023323369-A1 · Oct 12, 2023 · US
Novel drug-controlled systems and uses thereof
US-2023241026-A1 · Aug 3, 2023 · US
In vitro hbv core protein assay
US-2023228736-A1 · Jul 20, 2023 · US
Conjugate compounds for preventing and/or treating hbv and/or hdv infections, liver diseases andfor targeting ntcp
US-2023211003-A1 · Jul 6, 2023 · US
Drug-controlled systems and uses thereof
US-11660288-B2 · May 30, 2023 · US
Hepadnavirus capsid protein heterodimers and virus-like particles
US-2023083273-A1 · Mar 16, 2023 · US
Assay method and assay kit for hepatitis B virus S antigen
US-11454632-B2 · Sep 27, 2022 · US
Engineered hepatitis b core polypeptide
US-2022281924-A1 · Sep 8, 2022 · US
Novel drug-controlled systems and uses thereof
US-2022062234-A1 · Mar 3, 2022 · US
Engineered hepatitis B core polypeptide
US-11261216-B2 · Mar 1, 2022 · US
Hepatitis b virus replication inhibitor and pharmaceutical composition for treating hepatitis b comprising the same
US-2021332089-A1 · Oct 28, 2021 · US
Vaccine composition comprising hepatitis b virus-like particle as adjuvant
US-2021322544-A1 · Oct 21, 2021 · US
Vaccine composition comprising hepatitis B virus like particle as adjuvant
US-11116837-B2 · Sep 14, 2021 · US
Hepatitis b vaccine
US-2021228712-A1 · Jul 29, 2021 · US
Polypeptide carrier for presenting target polypeptide and uses thereof
US-10987418-B2 · Apr 27, 2021 · US
Modified antimicrobial peptide derived from an arginine-rich domain
US-2021101939-A1 · Apr 8, 2021 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/02?
- CPC C07K14/02 is the Cooperative Patent Classification code for “Hepadnaviridae, e.g. hepatitis B virus.”
- How many patents are filed under CPC C07K14/02 (Hepadnaviridae, e.g. hepatitis B virus)?
- Our database includes 46 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/02 growing?
- Publication counts under this code: 2 in 2024 vs 2 in 2025 (latest complete years).